serw-MX  [xml]  

 DeCS Categories

E05 Investigative Techniques .
E05.318 Epidemiologic Methods .
E05.318.760 Epidemiologic Study Characteristics .
E05.318.760.500 Epidemiologic Studies .
E05.318.760.500.950 Seroepidemiologic Studies .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.775 Epidemiologic Study Characteristics .
N05.715.360.775.175 Epidemiologic Studies .
N05.715.360.775.175.800 Seroepidemiologic Studies .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.450 Epidemiologic Study Characteristics .
N06.850.520.450.500 Epidemiologic Studies .
N06.850.520.450.500.950 Seroepidemiologic Studies .
SP4 Environmental Health .
SP4.001 Health .
SP4.001.012 Environmental Illness .
SP4.001.012.153 Epidemiology .
SP4. Epidemiologic Studies .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.012 Epidemiologic Studies .
SP5.001.012.033 Epidemiology, Descriptive .
SP5. Seroepidemiologic Studies .
SP5.001.012.038 Analytical Epidemiology .
SP5. Seroepidemiologic Studies .
 Synonyms & Historicals
Epidemiologic Studies .
Epidemiological Studies .
Studies, Epidemiologic .
Epidemiologic Study .
Epidemiological Study .
Studies, Epidemiological .
Study, Epidemiologic .
Study, Epidemiological .
Studies designed to examine associations, commonly, hypothesized causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are CASE-CONTROL STUDIES; COHORT STUDIES; and CROSS-SECTIONAL STUDIES. .
Seroepidemiologic Studies .
Seroepidemiologic Study .
Seroepidemiological Study .
Studies, Seroepidemiologic .
Study, Seroepidemiologic .
Seroepidemiological Studies .
Seroprevalences .
Studies, Seroepidemiological .
Study, Seroepidemiological .
Seroprevalence .
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. .